Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
prepared in cell cultures)
DRUG
2 trials
Sponsors
Novartis Pharma AG
, Centre Hospitalier Universitaire De Saint Etienne
Conditions
Adults seeking active immunisation against the seasonal influenza virus
Relapsing multiple sclerosis (RMS)
Phase 3
An open-label, single arm, multi-center extension study evaluating long-term safety, tolerability and effectiveness of ofatumumab in subjects with relapsing multiple sclerosis (RMS)
Active, not recruiting
CTIS2023-507906-15-00
Novartis Pharma AG
Relapsing multiple sclerosis (RMS)
Start: 2019-01-30
Target: 963
Updated: 2025-11-14
Phase 4
Impact of influenza vaccination on nasal resident memory immune responses and respiratory peripheral memory immune responses - MUCOVAC 2
Completed
CTIS2025-521217-46-00
Centre Hospitalier Universitaire De Saint Etienne
Adults seeking active immunisation against the seasonal influenza virus
Start: 2025-12-02
End: 2026-01-22
Target: 30
Updated: 2025-12-02